Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Sanofi To Publish COVID-19 Vaccine Price In Development With GSK After Phase I/II Trial Results

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

Photo Credit :

1606996565_pOgj8a_2020_12_03T115407Z_1_LYNXMPEGB20VL_RTROPTP_4_HEALTH_CORONAVIRUS_VACCINE_1_.JPG

French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.

The company is expected to release the results from the Phase I/II clinical trials this month.

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

(Reuters)


Tags assigned to this article:
COVID-19 Vaccine sanofi development